(Q53229530)

12 May 2018

title

Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers. (English)

1 reference

12 May 2018

1 reference

0 references

0 references

1 reference

González C

1

1 reference

12 May 2018

Martín T

2

1 reference

12 May 2018

Cacho J

3

1 reference

12 May 2018

Breñas MT

4

1 reference

12 May 2018

Arroyo T

5

1 reference

12 May 2018

García-Berrocal B

6

1 reference

12 May 2018

Navajo JA

7

1 reference

12 May 2018

González-Buitrago JM

8

1 reference

12 May 2018

publication date

1 July 1999

1 reference

12 May 2018

European Journal of Clinical Investigation

published in

1 reference

12 May 2018

volume

29

1 reference

12 May 2018

page(s)

637-642

1 reference

12 May 2018

issue

7

1 reference

12 May 2018

The genetics of Alzheimer disease: current status and future prospects

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Alpha-2 macroglobulin is genetically associated with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Rapid induction of Alzheimer A beta amyloid formation by zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Metallothioneins in brain--the role in physiology and pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

A novel metalloprotease in rat brain cleaves the amyloid precursor protein of Alzheimer's disease generating amyloidogenic fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Hyperinsulinaemia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Alterations in glucose metabolism in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Influence of apo E phenotype on postprandial triglyceride and glucose responses in subjects with and without coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Constellation of risks and processes seen in search for Alzheimer's clues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Multiple testing of hypotheses in comparing two groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Peripheral glucose metabolism and insulin sensitivity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Marked hyperinsulinaemia in postmenopausal, healthy Indian (Asian) women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

The relation of apolipoprotein E polymorphism to multiple cardiovascular risk in children: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Apolipoprotein E polymorphism and insulin levels in a biethnic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Impact of apolipoprotein E genotype variation on means, variances, and correlations of plasma lipid, lipoprotein, and apolipoprotein traits in octogenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

Statement on Use of Apolipoprotein E Testing for Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1999.00471.X

10.1046/J.1365-2362.1999.00471.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

10411671

1 reference

12 May 2018